Periodontitis, Chronic
7
1
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
14%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
MIST Versus M-MIST for the Treatment of Intrabony Defects
3-Month Clinical Trial of Liquid S-PRF in Periodontal Debridement for Periodontitis Stages II-IV
Impact of Periodontal Inflammation on Allostatic Load
Assessment of Masticatory Performance in Periodontitis
Effects of Antimicrobial Photodynamic Therapy on Regeneration of Class II Furcation Lesions
Adjunctive Hydrogen Peroxide for Periodontal Therapy
Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction